insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.04
arrow_downward
-3.70%(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
0.00
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
0.00
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
MarketWatch
·
43 minutes ago
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
Investing.com
·
1 hour ago
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
The Motley Fool
·
2 hours ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
50 minutes ago
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com